ARID1A c.6264_6266del ;(p.L2089del)

Variant ID: 1-27106650-ACTC-A

NM_006015.4(ARID1A):c.6264_6266del;(p.L2089del)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial.

Ebiomedicine
Hoyer, K K; Hablesreiter, R R; Inoue, Y Y; Yoshida, K K; Briest, F F; Christen, F F; Kakiuchi, N N; Yoshizato, T T; Shiozawa, Y Y; Shiraishi, Y Y; Striefler, J K JK; Bischoff, S S; Lohneis, P P; Putter, H H; Blau, O O; Keilholz, U U; Bullinger, L L; Pelzer, U U; Hummel, M M; Riess, H H; Ogawa, S S; Sinn, M M; Damm, F F
Publication Date: 2021-04

Variant appearance in text: ARID1A: 6262_6264del
PubMed Link: 33862582
Variant Present in the following documents:
  • mmc3.xlsx, sheet 2
View BVdb publication page



Hypermutation and unique mutational signatures of occupational cholangiocarcinoma in printing workers exposed to haloalkanes.

Carcinogenesis
Mimaki, Sachiyo S; Totsuka, Yukari Y; Suzuki, Yutaka Y; Nakai, Chikako C; Goto, Masanori M; Kojima, Motohiro M; Arakawa, Hirofumi H; Takemura, Shigekazu S; Tanaka, Shogo S; Marubashi, Shigeru S; Kinoshita, Masahiko M; Matsuda, Tomonari T; Shibata, Tatsuhiro T; Nakagama, Hitoshi H; Ochiai, Atsushi A; Kubo, Shoji S; Nakamori, Shoji S; Esumi, Hiroyasu H; Tsuchihara, Katsuya K
Publication Date: 2016-08

Variant appearance in text: ARID1A: L2088del
PubMed Link: 27267998
Variant Present in the following documents:
  • Main text
  • supp_bgw066_Supplementary_File_1_151127.xlsx, sheet 9
  • bgw066.pdf
View BVdb publication page